D-0066-2021 Class III Terminated
FDA drug recall D-0066-2021 was initiated by Jubilant Cadista Pharmaceuticals, Inc. on Oct 26, 2020 and is designated Class III. Reason for recall: Subpotent The recall status is terminated (terminated Aug 11, 2021). Affected quantity: 23,616 blister packs.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 11, 2020
- Initiation Date
- Oct 26, 2020
- Termination Date
- Aug 11, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 23,616 blister packs
Product description
Olanzapine Orally Disintegrating Tablets, 5 mg, 30 count (3x10 unit dose) blister pack, Rx only, Manufactured by: Jubilant Generics, Ltd., Roorkee, India, Marketed by: Jubilant Cardista Pharmaceuticals, Inc., Salisbury, MD NDC 59746-0306-32
Reason for recall
Subpotent
Distribution pattern
Product was distributed nationwide
Code information
Lot # AE119001A, exp. date 01/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0066-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026